INTRODUCTION AND OBJECTIVES: "Vaginal rejuvenation", or "#vejuvenation" as referenced on social media, is a phrase frequently encountered in popular culture today. However, there is no widely accepted definition for what this phrase encompasses, and there is no ICD-10 diagnosis or procedure code under which to bill for this treatment. Additionally, the FDA recently issued a statement warning against certain devices marketed specifically for this purpose. We aimed to investigate how individuals working in the healthcare profession and the general population interpret "vaginal rejuvenation."
METHODS: We administered a standardized survey to 40 people, including 22 healthcare professionals in urology, gynecology, plastic surgery, internal medicine, or nursing, as well as 18 lay people. We inquired as to whether they had heard the term "vaginal rejuvenation," whether it was a surgery/procedure or non-procedural treatment, what it is, how it helps, when it should be used, why people have vaginal rejuvenation, and how vaginal rejuvenation is performed.
RESULTS: Thirty-three of respondents (82.5%) were familiar with the term, 31 (77.5%) thought it was a surgery/procedure, and 13 (32.5%) thought it was a non-procedural treatment.
"Vaginal rejuvenation" as a catch-all phrase for a myriad of procedures was a commonly shared opinion among medical professionals to include vaginal procedures with varied energy sources (laser, thermal, ultrasound) and pelvic reconstructive procedures (perineoplasty, perineorrhaphy, prolapse repair, labioplasty). Use of vaginal laser was by far the most commonly mentioned procedure. The phrase was called "colloquial" and "loose," and repeatedly described as a marketing strategy. In regards to how "vaginal rejuvenation" helps patients, there were the following main themes: anatomic alteration (vaginal tightening, repairing prolapse, improving cosmetic appearance); symptomatic improvement (relieving atrophy/dyspareunia, restoring normal sexual/urinary/defecatory dysfunction, enhancing sexual pleasure); placebo effect; no help at all. It was almost unanimous among healthcare providers that patients should only pursue "vaginal rejuvenation" procedures when symptomatic or medically indicated.
In contrast to healthcare professionals, lay people tended to think of "vaginal rejuvenation" in terms of results as opposed to a specific procedure: treatment to address vaginal "dryness," "painful sex," and "incontinence." The large majority mentioned improved cosmesis, increased sexual sensation, and particularly "tightening" of the vagina. Five (12.5%) lay people mentioned a medical reason for receiving "vaginal rejuvenation" (dyspareunia, incontinence), and five also thought it was a procedure performed with a laser, although eight (20%) had no idea how it was done.
CONCLUSIONS: The term "vaginal rejuvenation" is ill-defined and elicits a highly variable description among healthcare professionals and lay persons alike. Indications for receiving it are not well aligned between providers and patients. Knowledgeable providers should use this information to counsel against widespread misunderstanding in popular culture.
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Ian Metzler*, David Bayne, San Francisco, CA; Helena Chang, Santa Clara, CA; Mohamed Jalloh, Dakar, Senegal; Ira Sharlip, San Francisco, CA INTRODUCTION AND OBJECTIVES: International volunteer organizations foster collaboration between urologists across borders, but the variance of and challenges to providing urologic care in resource-constrained settings is not well characterized, leading to scattered and misdirected aid.
METHODS: An online survey was developed in RedCapä with 70 distinct questions written in English. The surveys were distributed to urologists who had practiced in countries outside of the United States and Europe through personal contact, social networking sites and letters to regional urologic societies. Response countries of practice were categorized by World Bank income groups: high income countries (HICs) and low and middle income countries (LMICs).
RESULTS: 114 urologists from 27 countries completed the survey; 35 (39%) practiced in HICs while 54 (61%) practiced in LMICs. The mean age was 46 years, 11% were female and 43% percent of urologists received training outside their home country. The most common conditions treated were urolithiasis (30%), BPH (15%) and prostate cancer (13%) which did not vary by income group. Only 19% of urologists in LMICs reported sufficient urologists in their country compared to 68% of urologists in HICs. Patients in LMICs are less likely to get urgent drainage for infected obstructing kidney stones or endoscopic treatment for a painful kidney stone (p[0.009). Local LMIC urologists were more likely to cite financial challenges, access to diagnostics, support staff and surgical training as major barriers to care whereas urologists visiting LMICs were more likely to cite knowledge, operative facilities and access to disposables as the major challenges.
CONCLUSIONS: LMICs are lacking enough urologists to care for their population and nearly half of all urologists surveyed received urologic training outside their home country suggesting that access to urologic education is limited. There is disconnect between the needs identified by local and visiting urologists. International collaborations need to target broader interventions in LMICs to address local priorities such as diagnostic studies, support staff and financial support.
